Clinical data | |
---|---|
Trade names | Minocin, Amzeeq, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682101 |
License data |
|
Pregnancy category |
|
Routes of administration | By mouth, intravenous, topical |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 90–100%[4] |
Protein binding | 70–75%[5] |
Metabolism | Liver[5] |
Elimination half-life | 14–22[5] (11–26[4]) hours |
Excretion | Mostly fecal, 10–15% renal[5] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.226.626 |
Chemical and physical data | |
Formula | C23H27N3O7 |
Molar mass | 457.483 g·mol−1 |
3D model (JSmol) | |
Specific rotation | = −166°[5] |
Solubility in water | Low |
| |
| |
(what is this?) (verify) |
Minocycline, sold under the brand name Minocin among others, is a tetracycline antibiotic medication used to treat a number of bacterial infections such as some occurring in certain forms of pneumonia.[2][4][7] It is generally (but not always) less preferred than the tetracycline doxycycline.[4][7] Minocycline is also used for the treatment of acne and rheumatoid arthritis.[7][3] It is taken by mouth or applied to the skin.[4][3]
Common side effects include nausea, diarrhea, dizziness, allergic reactions, and kidney problems.[4] Serious side effects may include anaphylaxis, a lupus-like syndrome, and easy sunburning.[4] Use in the later part of pregnancy may harm the baby and safety during breastfeeding is unclear.[8] It works by decreasing a bacterium's ability to make protein thus stopping its growth.[4]
Minocycline was patented in 1961 and came into commercial use in 1971.[9] It is available as a generic medication.[7][10] In 2022, it was the 269th most commonly prescribed medication in the United States, with more than 900,000 prescriptions.[11][12]